Clinical Trials
3 trialsNCT00108056 2019-12-05
Enzastaurin to Treat Recurrent Brain Tumor
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT01445119 2013-08-28
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
Eli Lilly and Company
Phase 1 Completed
NCT00190723 2007-01-26
A Study of LY317615 in Patients With Brain Tumors
Eli Lilly and Company
Phase 2 Completed